M K Parmar

发表

Preoperative radiotherapy for esophageal carcinoma.

W Duncan, J F Tierney, M. Parmar, 2005, The Cochrane database of systematic reviews.

Tutorial in biostatistics Bayesian data monitoring in clinical trials.

P M Fayers, P. Fayers, M. Parmar, 1997, Statistics in medicine.

Applying Bayesian ideas in drug development and clinical trials.

D J Spiegelhalter, L S Freedman, D. Spiegelhalter, 1993, Statistics in medicine.

Assessing whether to perform a confirmatory randomized clinical trial.

R Simon, M. Parmar, R. Simon, 1996, Journal of the National Cancer Institute.

The what, why and how of Bayesian clinical trials monitoring.

D J Spiegelhalter, L S Freedman, D. Spiegelhalter, 1994, Statistics in medicine.

Monitoring clinical trials: experience of, and proposals under consideration by, the Cancer Therapy Committee of the British Medical Research Council.

D Machin, M. Parmar, D. Machin, 1993, Statistics in medicine.

Randomised consent designs in cancer clinical trials.

D G Altman, J Whitehead, D Machin, 1995, European journal of cancer.

Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group.

R A Risdon, M. Parmar, F. Mostofi, 1991, British journal of urology.

A unified method for monitoring and analysing controlled trials.

D J Spiegelhalter, L S Freedman, M K Parmar, 1994, Statistics in medicine.

Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

L S Freedman, M. Parmar, L. Freedman, 1989, The Journal of urology.